The investigation demonstrated that dual targeting of DOT1L and EZH2 effectively prevented human GCB-DLBCL xenograft growth ...

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy. Blood 109 , 4930–4935 (2007). Article CAS ...

Fox Chase Cancer Center: "Three Reasons to Seek A Second Opinion for Lymphoma." Leukemia & Lymphoma Society: "Support Groups." Lymphoma Action: "Diffuse Large B-Cell Lymphoma," "Staging of ...

Constitutive activation of the nuclear factor (NF)–κB pathway is essential for the survival of the least curable type of diffuse large B ... only 3.8% of germinal center B cell-like DLBCL ...

If you or a loved one has diffuse large B-cell lymphoma (DLBCL ... MD Anderson Cancer Center: “9 things to know about CAR T-cell therapy.” RWJ Barnabas Health: “Advantages of CAR-T Cell ...

Diffuse large B-cell lymphoma (DLBCL) is the most common and fast-growing type of non-Hodgkin lymphoma, a cancer that affects the lymphatic system. It makes up around 30–40% of adult non-Hodgkin ...